We’re excited to announce that the research protocol for our second clinical study has been officially approved. This new registry will be conducted at the Instituto Nacional de Cardiología Ignacio Chávez in Mexico — a major milestone for CardioTherMetrics in our mission to transform heart failure diagnostics.

The study will be led by Dr. Antonio Carlos Jordán, who joins the project as Principal Investigator. His leadership and expertise will be crucial in advancing this new phase of our research.

This achievement is the result of the dedication and hard work of our entire team — Nicolás Atamañuk, MD, MS; Gustavo Ross Quaas; Dario Wainer; and Ignacio J. Gandino — and the strong partnership we’ve developed with the Instituto Nacional de Cardiología Ignacio Chávez.

With this new clinical study, we take another key step forward in validating our non-invasive, AI-powered diagnostic tool for heart failure. We look forward to sharing early findings in the coming months as we continue to push the boundaries of innovation in digital health.